BRIBF
Price:
$0.12545
Market Cap:
$664.57M
Brii Biosciences Limited engages in the development of medicines for the treatment of infectious and central nervous system diseases. The company develops BRII-778 and BRII-732, which are in phase I clinical trials for the treatment of HIV patients; BRII-179 and BRII-835, which are in Phase 2 to evaluate the combination of these two HBV mechanisms for Hepatitis B; BRII-179, a recombinant protein-based HBV immunotherapeutic candidate that is in Phase 1b/2a; BRII-835, which has completed Phase-2 for patients with chronic HBV infection; and Amubarvimab/romlusevimab combination therapy for the treatment of COVID-19. It also develops BRII-296 for the treatment of PPD; BRII-297 for treatment of va...[Read more]
Industry
Biotechnology
IPO Date
2022-01-21
Stock Exchange
PNK
Ticker
BRIBF
According to Brii Biosciences Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 10.21M. This represents a change of -98.38% compared to the average of 628.69M of the last 4 quarters.
The mean historical Enterprise Value of Brii Biosciences Limited over the last ten years is 6.69B. The current 10.21M Enterprise Value has changed -84.73% with respect to the historical average. Over the past ten years (40 quarters), BRIBF's Enterprise Value was at its highest in in the September 2021 quarter at 9.20B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.
Average
6.69B
Median
4.84B
Minimum
701.53M
Maximum
12.67B
Discovering the peaks and valleys of Brii Biosciences Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 12.67B
Minimum Annual Increase = -80.31%
Minimum Annual Enterprise Value = 701.53M
Year | Enterprise Value | Change |
---|---|---|
2023 | 701.53M | -80.31% |
2022 | 3.56B | -26.33% |
2021 | 4.84B | -58.54% |
2020 | 11.67B | -7.96% |
The current Enterprise Value of Brii Biosciences Limited (BRIBF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.03B
5-year avg
6.69B
10-year avg
6.69B
Brii Biosciences Limited’s Enterprise Value is less than Avalo Therapeutics, Inc. (24.69M), greater than Alzamend Neuro, Inc. (4.67M), greater than Virax Biolabs Group Limited (5.36M), less than Kiromic BioPharma, Inc. (13.48M), less than Benitec Biopharma Inc. (175.91M), greater than Cardio Diagnostics Holdings, Inc. (9.47M), less than Sigilon Therapeutics, Inc. (42.21M), greater than Sonnet BioTherapeutics Holdings, Inc. (-907921.00), greater than ZyVersa Therapeutics, Inc. (2.53M), less than X4 Pharmaceuticals, Inc. (38.44M), less than Terns Pharmaceuticals, Inc. (222.97M), less than 89bio, Inc. (940.63M), greater than Cabaletta Bio, Inc. (-63983636.00), less than Akero Therapeutics, Inc. (2.00B), less than Mirum Pharmaceuticals, Inc. (2.24B), less than Inozyme Pharma, Inc. (202.73M), less than Day One Biopharmaceuticals, Inc. (963.46M), greater than HOOKIPA Pharma Inc. (-36166707.00), less than Axsome Therapeutics, Inc. (4.65B), less than Incyte Corporation (12.55B), less than ImmunoGen, Inc. (8.19B), less than Sarepta Therapeutics, Inc. (12.11B), less than ACADIA Pharmaceuticals Inc. (2.61B),
Company | Enterprise Value | Market cap |
---|---|---|
24.69M | $106.00M | |
4.67M | $5.86M | |
5.36M | $8.73M | |
13.48M | $1.69M | |
175.91M | $243.54M | |
9.47M | $10.73M | |
42.21M | $56.22M | |
-907921.00 | $2.50M | |
2.53M | $2.65M | |
38.44M | $57.64M | |
222.97M | $491.80M | |
940.63M | $1.03B | |
-63983636.00 | $91.40M | |
2.00B | $2.28B | |
2.24B | $2.15B | |
202.73M | $180.51M | |
963.46M | $1.38B | |
-36166707.00 | $20.76M | |
4.65B | $4.78B | |
12.55B | $13.82B | |
8.19B | $8.73B | |
12.11B | $10.91B | |
2.61B | $2.72B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Brii Biosciences Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Brii Biosciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Brii Biosciences Limited's Enterprise Value?
What is the highest Enterprise Value for Brii Biosciences Limited (BRIBF)?
What is the 3-year average Enterprise Value for Brii Biosciences Limited (BRIBF)?
What is the 5-year average Enterprise Value for Brii Biosciences Limited (BRIBF)?
How does the current Enterprise Value for Brii Biosciences Limited (BRIBF) compare to its historical average?